Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 69
Filtrar
2.
Reprod Toxicol ; 58: 15-23, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26216787

RESUMO

Classification of substances as teratogenic is based on the observation of external, visceral and skeletal anomalies. Characterization of anomalies as variation or malformation is contingent upon their postnatal persistence and adversity to health. Lack of information thereof may result in inconsistent or incorrect classification. The aim of this work is the examination of vertebral skeletal anomalies regarding their postnatal fate on PNDs 7 and 21. The anomalies unossified, asymmetric ossification, bipartite ossification, hemicentric, as well as misshapen, did not persist up to PND21 and should be classified as a variation. The finding, cervical vertebra centrum dumbbell-shaped, should be categorized as a malformation due to its continued presence on PND 21. Lumbar centrum supernumerary sinister/dexter/sinister+dexter should also be classified as a malformation. This study demonstrates that postnatal examination is useful and substantially improves the ability to perform a scientifically sound classification of an anomaly compared to investigations terminated on GD 21.


Assuntos
Anormalidades Induzidas por Medicamentos/classificação , Anormalidades Induzidas por Medicamentos/etiologia , Floxuridina/classificação , Floxuridina/toxicidade , Efeitos Tardios da Exposição Pré-Natal , Coluna Vertebral/anormalidades , Coluna Vertebral/efeitos dos fármacos , Teratogênicos/classificação , Teratogênicos/toxicidade , Terminologia como Assunto , Fatores Etários , Animais , Feminino , Idade Gestacional , Masculino , Gravidez , Ratos Wistar , Medição de Risco , Toxicologia/métodos
3.
Reprod Toxicol ; 31(4): 574-84, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21338671

RESUMO

There is growing concern that environmental substances with a potential to modulate the hormonal system may have harmful effects on human health. Consequently, a new EU regulation names endocrine disrupting properties as one of the cut-off criteria for the approval of plant protection products, although it currently fails to provide specific science-based measures for the assessment of substances with such properties. Since specific measures are to be presented by the European Commission in 2013 the development of assessment and decision criteria is a key challenge concerning the implementation of this new EU regulation. Proposals of such decision criteria for substances with potential endocrine disrupting properties in human health risk assessment were developed by the German Federal Institute for Risk Assessment (BfR) and discussed at an expert workshop in November 2009. Under consideration of the requirements laid down within the new plant protection product legislation and the scientific discussions during the workshop, a conceptual framework on evaluation of substances for endocrine disrupting properties in a regulatory context is presented in this paper. Central aspects of the framework include assessment of adversity of effects, establishment of a mode/mechanism of action in animals, considerations concerning the relevance of effects to humans and two options for a regulatory decision.


Assuntos
Disruptores Endócrinos/toxicidade , Monitoramento Ambiental , Praguicidas/toxicidade , Testes de Toxicidade , Animais , Mineração de Dados , Bases de Dados Factuais , Técnicas de Apoio para a Decisão , Monitoramento Ambiental/legislação & jurisprudência , Monitoramento Ambiental/normas , Europa (Continente) , Guias como Assunto , Humanos , Medição de Risco , Testes de Toxicidade/normas
4.
Environ Res ; 101(1): 81-8, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16162336

RESUMO

In a one-generation reproductive study, the fungicidal compound triphenyltin hydroxide (fentin) was administered to adult Japanese quail for 6 weeks at dietary levels of 3 and 30 ppm. Reproduction was significantly impaired in the high-dose group. The principal adverse finding was a marked increase in embryonic mortality, resulting in a lower hatch rate. Furthermore, a reduction in egg production was observed with ongoing duration of treatment. Most of the other reproduction-related parameters were not affected. The in ovo losses are assumed to result from a direct toxic effect of the test substance on chick embryos. At the low dietary level, reproduction was not altered. In contrast to the obvious reproductive toxicity, there was only limited evidence of adverse treatment-related findings in the adult birds. However, because such minor effects as an increase in mean liver weight, which was accompanied by macroscopic liver findings and a decrease in T4 serum concentration, were still seen at 3 ppm, a no-observed-effect level could not be established.


Assuntos
Coturnix/fisiologia , Compostos Orgânicos de Estanho/toxicidade , Reprodução/efeitos dos fármacos , Animais , Casca de Ovo/efeitos dos fármacos , Estradiol/sangue , Feminino , Masculino , Nível de Efeito Adverso não Observado , Testosterona/sangue , Tiroxina/sangue
5.
Braz J Med Biol Res ; 38(4): 565-75, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15962182

RESUMO

We investigated the relationship between fetal body weight at term (pregnancy day 21) and the extent of ossification of sternum, metacarpus, metatarsus, phalanges (proximal, medial and distal) of fore- and hindlimbs and cervical and coccygeal vertebrae in Wistar rats. The relationships between fetal body weight and sex, intrauterine position, uterine horn, horn size, and litter size were determined using historical control data (7594 fetuses; 769 litters) of untreated rats. Relationships between body weight and degree of ossification were examined in a subset of 1484 historical control fetuses (154 litters) which were subsequently cleared and stained with alizarin red S. Fetal weight was independent of horn size, uterine horn side (left or right) or intrauterine position. Males were heavier than females and fetal weight decreased with increasing litter size. Evaluation of the skeleton showed that ossification of sternum, metacarpus and metatarsus was extensively complete and independent of fetal weight on pregnancy day 21. In contrast, the extent of ossification of fore- and hindlimb phalanges and of cervical and sacrococcygeal vertebrae was dependent on fetal body weight. The strongest correlation between body weight and degree of ossification was found for hindlimb, medial and proximal phalanges. Our data therefore suggest that, in full-term rat fetuses (day 21), reduced ossification of sternum, metacarpus and metatarsus results from a localized impairment of bone calcification (i.e., a malformation or variation) rather than from general growth retardation and that ossification of hindlimb (medial and proximal) phalanges is a good indicator of treatment-induced fetal growth retardation.


Assuntos
Desenvolvimento Fetal/fisiologia , Peso Fetal , Osteogênese/fisiologia , Animais , Feminino , Retardo do Crescimento Fetal/diagnóstico , Idade Gestacional , Tamanho da Ninhada de Vivíparos , Masculino , Gravidez , Ratos , Ratos Wistar
6.
Braz. j. med. biol. res ; 38(4): 565-575, Apr. 2005. ilus, tab, graf
Artigo em Inglês | LILACS | ID: lil-398184

RESUMO

We investigated the relationship between fetal body weight at term (pregnancy day 21) and the extent of ossification of sternum, metacarpus, metatarsus, phalanges (proximal, medial and distal) of fore- and hindlimbs and cervical and coccygeal vertebrae in Wistar rats. The relationships between fetal body weight and sex, intrauterine position, uterine horn, horn size, and litter size were determined using historical control data (7594 fetuses; 769 litters) of untreated rats. Relationships between body weight and degree of ossification were examined in a subset of 1484 historical control fetuses (154 litters) which were subsequently cleared and stained with alizarin red S. Fetal weight was independent of horn size, uterine horn side (left or right) or intrauterine position. Males were heavier than females and fetal weight decreased with increasing litter size. Evaluation of the skeleton showed that ossification of sternum, metacarpus and metatarsus was extensively complete and independent of fetal weight on pregnancy day 21. In contrast, the extent of ossification of fore- and hindlimb phalanges and of cervical and sacrococcygeal vertebrae was dependent on fetal body weight. The strongest correlation between body weight and degree of ossification was found for hindlimb, medial and proximal phalanges. Our data therefore suggest that, in full-term rat fetuses (day 21), reduced ossification of sternum, metacarpus and metatarsus results from a localized impairment of bone calcification (i.e., a malformation or variation) rather than from general growth retardation and that ossification of hindlimb (medial and proximal) phalanges is a good indicator of treatment-induced fetal growth retardation.


Assuntos
Animais , Feminino , Masculino , Gravidez , Ratos , Peso Fetal , Desenvolvimento Fetal/fisiologia , Osteogênese/fisiologia , Retardo do Crescimento Fetal/diagnóstico , Idade Gestacional , Tamanho da Ninhada de Vivíparos , Ratos Wistar
7.
Arch Environ Contam Toxicol ; 46(4): 528-33, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15253051

RESUMO

In a one-generation reproduction study, the major agricultural fungicide vinclozolin was administered to adult Japanese quail for a period of 6 weeks at dietary levels of 125 and 500 ppm. Fertility and reproductive performance were not affected up to the highest concentration, although the examination of additional endpoints in the drakes (spermatid count, histology of the testis) provided some evidence of an inhibition of spermatogenesis at both dietary concentrations. Likewise, there were no indications of systemic toxicity in the adult birds. Plasma hormone concentrations (estradiol, testosterone, progesterone, T3, and T4) showed a large interindividual variance but treatment-related differences between the groups could not be established. There were no clear-cut indications of antiandrogenic effects in quail, although a limited transfer of the test substance into the eggs was proven.


Assuntos
Coturnix/crescimento & desenvolvimento , Poluentes Ambientais/toxicidade , Fertilidade/efeitos dos fármacos , Oxazóis/toxicidade , Espermatogênese/efeitos dos fármacos , Administração Oral , Animais , Feminino , Hormônios Esteroides Gonadais/sangue , Masculino , Óvulo/efeitos dos fármacos , Contagem de Espermatozoides , Testículo/efeitos dos fármacos , Hormônios Tireóideos/sangue
8.
Neoplasia ; 4(2): 98-102, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-11896564

RESUMO

The origins of the "endocrine disrupter hypothesis" may be traced to reports on adolescent daughters born to women who had taken the highly potent synthetic estrogen, diethylstilbestrol, while pregnant, and who developed a rare form of vaginal cancer and adenocarcinoma. Bisphenol A (BPA) is an estrogenic chemical that is highly employed in the manufacture of a wide range of consumer products. Some observational studies have suggested that the amounts of BPA to which we are exposed could alter the reproductive organs of developing rodents. We examined the influence of BPA at low doses to address the questions of (a) whether in utero exposure affects the vagina of the offspring and (b) which mechanisms cause the toxic effects. Gravid Sprague-Dawley dams were administered either 0.1 (low dose) or 50 mg/kg per day BPA, the no observed effect level, or 0.2 mg/kg per day 17 alpha-ethinyl estradiol by gavage. Striking morphological changes were observed in the vagina of postpubertal offspring leading us to examine vaginal estrogen receptor (ER) expression because BPA binds to the ER alpha, which is important for growth of the vaginal epithelium. We show that the full-length ER alpha is not expressed during estrus in the vagina of female offspring exposed to either dose of BPA when compared to the control group, whereas ER alpha expression does not differ from the control group during the diestrus stage. ER alpha downregulation seems to be responsible for the observed altered vaginal morphology.


Assuntos
Estrogênios não Esteroides/toxicidade , Fenóis/toxicidade , Vagina/efeitos dos fármacos , Animais , Compostos Benzidrílicos , Western Blotting , Diestro/efeitos dos fármacos , Receptor alfa de Estrogênio , Estro/efeitos dos fármacos , Feminino , Lactação , Ovariectomia , Ovário/efeitos dos fármacos , Ovário/fisiologia , Gravidez , Efeitos Tardios da Exposição Pré-Natal , Ratos , Ratos Sprague-Dawley , Receptores de Estrogênio/metabolismo , Vagina/metabolismo , Vagina/patologia
9.
Reprod Toxicol ; 15(6): 713-21, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11738525

RESUMO

The initial efforts of the Federal Institute for Health Protection of Consumers and Veterinary Medicine (BgVV) and the Free University of Berlin to standardise terminology in the field of developmental toxicology began in 1995. Procedures were undertaken to harmonise the terminology used by the International Federation of Teratology Societies (IFTS) and the International Programme on Chemical Safety (IPCS). This article reflects these activities and is a report on the Third Workshop on the Terminology in Developmental Toxicology held in September 2000. This Workshop served as a forum to discuss the results of a survey on the classification of skeletal anomalies that had been previously sent to scientists active in the field. Although high agreement was reached among the evaluators for several terms, the use of a number of terms was rather variable. Therefore, the discussions at the workshop among the experts from research institutions, regulatory agencies, and industry were mainly focussed on those terms for which there was disagreement and/or uncertainties and the possible reasons. Pictures provided by the participants for the illustration of "grey zone" anomalies constituted the basis for detailed discussions. In many of the cases with lower agreement, decisions were facilitated by the provision of the corresponding picture. The main reasons for lower agreement were imprecise terms, insufficient knowledge on postnatal consequences, theoretical terms that are unlikely to occur in isolation, and the possibility of observing a range of severity that might be decisive for the classification of either a malformation or variation. The attendees concluded that "grey-zone" anomalies will never disappear completely and that for the assessment, the grade of severity and/or the frequency of the observation can be decisive for the terminology chosen. A Joint IPCS/IFTS Project was proposed to further consensus of terminology and classification and to link these anomalies to pictures at different skeletal sites. In order to support the harmonisation of regulatory decisions, it was proposed to establish a "Clearinghouse" System under the umbrella of the IPCS. The Clearinghouse could be contacted either by the regulatory authorities or by any company to clarify their queries, particularly with regard to registration or authorisation processes. Finally, it was recommended to also carry out a similar survey on "soft tissue anomalies" and "external findings." The results of this survey will be discussed at a Joint IPCS/IFTS Workshop in Berlin in 2002.


Assuntos
Anormalidades Induzidas por Medicamentos , Osso e Ossos/anormalidades , Cooperação Internacional , Terminologia como Assunto , Toxicologia/normas , Animais , Osso e Ossos/efeitos dos fármacos , Humanos , Ratos
11.
Reprod Toxicol ; 15(3): 327-31, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11390176

RESUMO

Meglumine antimoniate (MA) is a pentavalent antimonial (Sb(V)) drug used to treat leishmaniasis. Despite the fact that Sb(V) organic compounds have been used in clinical practice for more than 50 years, information on their safety during pregnancy is still scanty. This study was undertaken to evaluate the embryo/fetotoxicity of MA in the rat. Wistar rats were treated subcutaneously (s.c.) with MA (300 mg Sb(V)/kg body wt/day) on days 6 through 15 of pregnancy or with a higher dose (3 x 300 mg Sb(V)/kg body wt) on day 11 only. A control group treated with saline on days 6 through 15 and an untreated control group were evaluated as well. Cesarean sections were performed on day 21. No maternal toxicity and no reduction of fetal weight were noted in the groups treated with MA. The repeated administration of MA (days 6 through 15), but not the acute treatment (day 11), enhanced embryolethality. Treatment with MA on days 6 through 15 also caused a higher incidence of an atlas bone anomaly that occurs spontaneously at very low frequencies in our rat strain. These findings indicated that repeated administration of MA was embryolethal and teratogenic in rats.


Assuntos
Anormalidades Induzidas por Medicamentos , Antiprotozoários/toxicidade , Embrião de Mamíferos/efeitos dos fármacos , Meglumina/toxicidade , Compostos Organometálicos/toxicidade , Teratogênicos/toxicidade , Animais , Antiprotozoários/administração & dosagem , Atlas Cervical/anormalidades , Atlas Cervical/efeitos dos fármacos , Feminino , Morte Fetal/induzido quimicamente , Peso Fetal/efeitos dos fármacos , Injeções Subcutâneas , Masculino , Meglumina/administração & dosagem , Antimoniato de Meglumina , Compostos Organometálicos/administração & dosagem , Gravidez , Ratos , Ratos Wistar , Organismos Livres de Patógenos Específicos , Testes de Toxicidade
12.
Reprod Toxicol ; 15(2): 117-22, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11297870

RESUMO

The octyltin stabilizer ZK 30.434 is a mixture of 80% dioctyltin diisooctylthioglycolate (DOTTG) and 20% of monooctyltin triisooctylthioglycolate (MOTTG) and is used as stabilizer for rigid polyvinylchloride (PVC) materials. One of the applications of such stabilized films is the packaging of foodstuffs. Exposure to humans occurs via migration of DOTTG/MOTTG from PVC materials. In the present study the developmental toxicity of DOTTG/MOTTG in NMRI mice was investigated. Dams were treated orally with doses of 20, 30, 45, 67, or 100 mg/kg/day DOTTG/MOTTG from gestation day 6 through 17 (plug = day 1). Resorption rates were significantly increased and fetal weights significantly reduced in the study group at the 2 highest doses. External anomalies, such as bent forelimbs, cleft palate, and exencephaly were reported in the group treated with 100 mg/kg/day DOTTG/MOTTG, with the 67-mg/kd dose also exhibiting a significant increase in cleft palate. Moreover, an increase in skeletal anomalies was reported in fetuses exposed to 100 mg/kg/day. The doses of 20, 30, and 45 mg/kg/day elicited a significant increase in supernumerary lumbar ribs. It can be concluded that DOTTG/MOTTG is embryo-fetotoxic and induces developmental effects. The study revealed the need for the establishment of different No-Observed Adverse Effect Levels (NOAEL) for the endpoints investigated.


Assuntos
Anormalidades Induzidas por Medicamentos , Compostos Organometálicos/toxicidade , Teratogênicos/toxicidade , Tioglicolatos/toxicidade , Animais , Peso Corporal/efeitos dos fármacos , Osso e Ossos/anormalidades , Osso e Ossos/efeitos dos fármacos , Fissura Palatina/induzido quimicamente , Relação Dose-Resposta a Droga , Feminino , Reabsorção do Feto/induzido quimicamente , Peso Fetal/efeitos dos fármacos , Membro Anterior/anormalidades , Membro Anterior/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fígado/patologia , Masculino , Camundongos , Defeitos do Tubo Neural/induzido quimicamente , Nível de Efeito Adverso não Observado , Tamanho do Órgão/efeitos dos fármacos , Compostos Organometálicos/administração & dosagem , Gravidez , Tioglicolatos/administração & dosagem , Timo/efeitos dos fármacos , Timo/patologia
13.
J Ethnopharmacol ; 74(2): 149-57, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11167033

RESUMO

Teas of Vernonia condensata Baker (Asteraceae) are widely used in Brazil for gastro-intestinal disorders and to treat several other diseases. In this study, we evaluated the acute toxicity, embryotoxicity and mutagenicity of a lyophilized aqueous extract (LAE) from V. condensata leaves. Single doses of LAE, up to 5000 mg/kg body weight, were given orally or intraperitoneally to male and female Swiss albino mice. No toxicity was observed after oral administration. The "Approximate Lethal Dose" after intraperitoneal injections was 3400 mg/kg for males and 5000 mg/kg for females. Embryotoxicity was investigated in Han:NMRI mice. LAE (0, 500 and 2000 mg/kg/day) was given by gavage on days 10, 11 and 12, and dams were submitted to caesarean sections on day 18 of pregnancy. Fetuses were weighed, examined for externally visible malformations, and evaluated for skeletal anomalies. Except for a slight reduction of fetal body weight accompanied by signs of delayed ossification at the highest dose, no other embryotoxic effect was noted in the exposed offspring. LAE-induced mutagenicity was evaluated in the Salmonella/microsome assay without and with S9 mixture. LAE, tested up to 5000 microg/plate, was not mutagenic to tester strains TA97a, TA98 and TA100. Results therefore suggest that V. condensata aqueous extracts present low acute toxicity and pose neither teratogenic nor mutagenic risks.


Assuntos
Asteraceae/química , Mutagênicos/toxicidade , Plantas Medicinais/química , Teratogênicos/toxicidade , Animais , Feminino , Masculino , Camundongos , Testes de Mutagenicidade , Extratos Vegetais/toxicidade , Folhas de Planta/química , Gravidez , Salmonella typhimurium/efeitos dos fármacos , Salmonella typhimurium/genética , Caracteres Sexuais , Aumento de Peso/efeitos dos fármacos
14.
Teratology ; 62(5): 291-300, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11029147

RESUMO

BACKGROUND: Indinavir is an antiviral agent used for the treatment of HIV infection. We studied its developmental toxicity in rats. METHODS: Pregnant animals were treated orally with 500 mg indinavir/kg body weight (bw) from day 6 to 15 of gestation (once daily) or from day 9 to 11 (twice daily). Fetuses were evaluated for external and skeletal anomalies on day 21 of gestation. In addition, 19 rats were treated from day 9 of gestation to day 24 postnatally with 500 mg indinavir/kg bw once daily; a control group of 17 rats was treated with the vehicle accordingly. Developmental landmarks were recorded. Sixteen offspring each were studied on postnatal days 7, 14, 21, and 35 for hepatic enzyme activity. Liver tissue was examined by electron microscopy. RESULTS: Fetal examination on day 21 of pregnancy showed no treatment-related effects on number, weight, and viability of the fetuses; however, an increased incidence was noted in the supernumerary ribs and variations of the vertebral ossification centers in both indinavir-treated groups. Postnatal evaluation showed delayed fur development, eye opening, and descensus testis. The most striking finding was unilateral anophthalmia, observed in 7 pups (3%) from 2 out of 19 litters exposed to indinavir, but not in controls. Only minor changes in hepatic monooxygenase activities occurred in dams. Electron microscopy of liver samples showed hepatocellular inclusions of lipids and myelin figure-like structures in maternal livers and infiltration with granulocytes in offspring livers. CONCLUSIONS: Further studies on reproductive toxicity, including combinations of three or more antiretroviral agents as used therapeutically, are needed to determine the hazards of such a treatment.


Assuntos
Anormalidades Induzidas por Medicamentos/etiologia , Anoftalmia/induzido quimicamente , Desenvolvimento Embrionário e Fetal/efeitos dos fármacos , Inibidores da Protease de HIV/toxicidade , Indinavir/toxicidade , Ossificação Heterotópica/induzido quimicamente , Costelas/anormalidades , Anormalidades Induzidas por Medicamentos/enzimologia , Animais , Peso Corporal/efeitos dos fármacos , Sistema Enzimático do Citocromo P-450/metabolismo , Relação Dose-Resposta a Droga , Feminino , Feto/efeitos dos fármacos , Feto/patologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Fígado/ultraestrutura , Masculino , Microscopia Eletrônica , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/metabolismo , Gravidez , Ratos , Ratos Wistar , Coluna Vertebral/anormalidades , Coluna Vertebral/patologia
15.
Environ Res ; 83(3): 293-7, 2000 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10944073

RESUMO

The levels of polychlorinated dibenzo-p-dioxins (PCDDs) and -furans (PCDFs), polychlorinated biphenyls (PCBs), and other organochlorine compounds were determined in a pooled sample of breast milk from 40 mothers (first lactation: 33; second lactation: 7, age: 15-38 years) living in the urban area of Rio de Janeiro County, Brazil, in 1992. Mothers were breastfeeding only one infant and milk was collected between 4 and 6 weeks after delivery. The results showed a dioxin equivalent concentration of 8.1 pg I-TEq/g milk fat. The levels of other chlorinated compounds (micrograms per gram of milk fat) were as follows: PCBs (total), 0.15; alpha-HCH, 0.001; beta-HCH, 0.27;gamma-HCH, 0.005; HCB, 0.012; DDT (total), 1.7; dieldrin, 0.023, and cis-heptachlor epoxide, 0.008. These results suggest that human background contamination by PCDD/Fs, PCBs, and HCB in Rio de Janeiro is lower than that generally found in industrialized countries.


Assuntos
Benzofuranos/análise , Poluentes Ambientais/análise , Leite Humano/química , Bifenilos Policlorados/análise , Dibenzodioxinas Policloradas/análogos & derivados , Adolescente , Adulto , Brasil , Exposição Ambiental , Feminino , Humanos , Dibenzodioxinas Policloradas/análise
16.
J Mol Med (Berl) ; 78(2): 102-10, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10794546

RESUMO

The present study focuses on the establishment and characterization of a new follicular thyroid carcinoma cell line. The human cell line ML-1 was derived from a dedifferentiated follicular thyroid carcinoma relapse, which progressed despite preceding surgery followed by two radioiodine therapies. More than 90% of the cells of this line express thyroglobulin, chondroitin sulfate, and vimentin antigens, but only about 70% show cytokeratin filaments and a negative surface charge density such as human erythrocytes. More importantly, cells of this line are able to take up iodine and/or glucose both in vitro and in vivo and to secrete thyroglobulin, chondroitin sulfate, and fibronectin into the interstitial space. In addition, triiodothyronine is released constitutively into culture supernatants. Moreover, it is also suitable for xenotransplantation studies because it is tumorigenic in NMRI nude mice in vivo. The cell line forms tumors with follicular structures when transplanted to nude mice. Due to these unique features the ML-1 cell line can be considered as a very suitable test model for pharmacological and cell biological studies. Since chemicals may interfere with the production of thyroid hormones, this cell line represents also a tool for toxicological investigations.


Assuntos
Adenocarcinoma Folicular/patologia , Neoplasias da Glândula Tireoide/patologia , Células Tumorais Cultivadas/citologia , Animais , Transplante de Células , DNA de Neoplasias/análise , Desoxiglucose/metabolismo , Feminino , Citometria de Fluxo , Humanos , Imuno-Histoquímica , Iodo/metabolismo , Masculino , Camundongos , Camundongos Nus , Pessoa de Meia-Idade , Transplante de Neoplasias , Tireoglobulina/metabolismo , Transplante Heterólogo , Tri-Iodotironina/metabolismo , Células Tumorais Cultivadas/metabolismo , Células Tumorais Cultivadas/transplante
18.
Hum Exp Toxicol ; 18(11): 683-90, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10602393

RESUMO

1. The reproductive effects of 2-bromopropane (2-BP) in sexually mature and immature male Sprague-Dawley rats were investigated. The animals were randomly divided into three treatment groups and one control group each of which comprised six mature and six immature rats. The treated groups were injected s.c. 200, 600 and 1800 mg/kg of 2-BP on 5 days a week for 5 - 7 weeks and the control group received the vehicle. 2. The absolute and relative testis weights were significantly reduced in 600 and 1800 mg/kg b.w. dose groups in both mature and immature rats. The absolute epididymis, prostate, seminal vesicle, and pituitary weights and the relative epididymis weights, however, were significant only at the highest dose level used in both mature and immature rats. 3. The sperm concentration and sperm viability in epididymal duct decreased and the percentage of abnormal sperm increased in a dose-dependent manner in both mature and immature rats. Additionally, serum testosterone level was significantly decreased in all dose groups in mature rats, and was significantly reduced only in the group treated with the middle and highest dose in immature rats. 4. In both mature and immature rats treated with 200 and 600 mg/kg, the seminiferous tubules were atrophied and all types of germ cells were decreased in number. At the highest dose level, the effect was more marked showing severely atrophied seminiferous tubules and a complete loss of all types of germ cells. 5. The mating, pregnancy and fertility indices were significantly reduced in the 600 and 1800 mg/kg groups. Additionally, at the highest dose group the number of implantations and viable fetuses per litter were reduced and the resorption rate was increased significantly. 6. In the mature rats, the beta-LH gene expression increased significantly in the 1800 mg/kg group when compared to the control group. 7. It can be concluded that 2-BP induces alterations in both neuro-endocrine axis and the reproductive tract under the present experimental conditions. The no observed adverse effect level (NOAEL) in this study could be estimated to be lower than 200 mg/kg/b.w. based on the alteration in testicular morphology as well as on sperm parameters observed at the dose level of 200 mg/kg.


Assuntos
Expressão Gênica/efeitos dos fármacos , Hidrocarbonetos Bromados/toxicidade , Hormônio Luteinizante/biossíntese , Reprodução/efeitos dos fármacos , Maturidade Sexual/efeitos dos fármacos , Animais , Peso Corporal/efeitos dos fármacos , Epididimo/efeitos dos fármacos , Feminino , Fertilidade/efeitos dos fármacos , Hormônio Luteinizante/genética , Masculino , Tamanho do Órgão/efeitos dos fármacos , Hipófise/efeitos dos fármacos , Hipófise/metabolismo , Gravidez , Próstata/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Glândulas Seminais/efeitos dos fármacos , Razão de Masculinidade , Motilidade dos Espermatozoides/efeitos dos fármacos , Espermatozoides/citologia , Espermatozoides/efeitos dos fármacos , Testículo/efeitos dos fármacos , Testosterona/sangue
19.
Reprod Toxicol ; 13(5): 375-81, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10560586

RESUMO

It has been widely debated whether embryo/fetal toxicity is secondary to maternal toxicity. This argument has led to great difficulties for administrative decision makers involved in public health evaluation of drugs or chemicals. The present study sought to characterize whether there is a correlation between maternal toxicity and embryo/fetal toxicity. Developmental data from control and treated animals in our laboratory were collected and evaluated. Maternal toxicity, defined here as maternal body weight change, was statistically correlated with embryo/fetal parameters. The result showed that embryo/fetal parameters did not correlate with the body weight change. It can be concluded that maternal toxicity does not always lead to embryo/fetal toxicity; therefore, findings should be handled on a case by case basis and causal relationships should be established.


Assuntos
Anormalidades Induzidas por Medicamentos/etiologia , Embrião de Mamíferos/efeitos dos fármacos , Feto/efeitos dos fármacos , Teratogênicos/toxicidade , Animais , Peso Corporal/efeitos dos fármacos , Feminino , Reabsorção do Feto/induzido quimicamente , Peso Fetal/efeitos dos fármacos , Humanos , Masculino , Exposição Materna/efeitos adversos , Troca Materno-Fetal/efeitos dos fármacos , Gravidez , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA